Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSCLC

There is an urgent need for new therapeutics for the treatment of aggressive and metastatic refractory human non-small–cell lung cancer (NSCLC). Antiangiogenesis therapy and chemotherapy are the two major treatment options. Unfortunately, both types of therapies when used individually have their dis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zhang, Yuan, Schwerbrock, Nicole MJ, Rogers, Arlin B, Kim, William Y, Huang, Leaf
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2013
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3734668/
https://ncbi.nlm.nih.gov/pubmed/23774791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2013.120
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge